Meeting Patient Preferences

A new study has found that a patient’s preference for the time and place of their psychological treatment affects their perception of the treatment.

The study, from researchers at the Royal College of Psychiatrists and Imperial College London, looked at the treatment preferences of patients involved in the National Audit of Psychological Therapies according to five aspects: venue, time of day, gender of therapist, language that the treatment was delivered in, and therapy type.

For each of these features, the 14,587 patients were asked to rate whether or not they had a strong preference and if they were given enough choice. They were also asked to evaluate their satisfaction with treatment outcome using a five-point scale. MORE HERE

TravelTuesday

Tags

, ,

Since 2016 I have, on occasion, been traveling  in my little blue Yaris hatchback.  AND like every other blue 2008 Yaris it has a clear coat paint peeling problem. AND despite its looks the little bugger seems to putter along ok.

I am planning a slow drive across America. From Arizona to the tri-state area … arriving around the beginning of springish. I will be stopping at some historical, spiritual, and interesting sites. Between here and there …. it’s over 2000 miles so ……..
    !!Looking for suggestions!!

As a deeply spiritual person I like to spend a part of each day in prayer, just as I have done since I was a teen. Hopefully that will at least occasionally be at a community of faith and likely more often at a rest area on the interstate or at a park along one of the blue highways. [see: William Least Heat Moon].      !!Looking for suggestions!!

See: https://richardbbrunner.com/2025/09/13/excited-to-begin-trip-planning/

Medicare and Med prices

Tags

, , ,

The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) included a “non-interference clause” that officially prohibited Medicare from negotiating prescription drug prices directly with manufacturers.

This law established Part D and required private insurers to handle negotiations, allowing higher prices to prevail until the Inflation Reduction Act of 2022 (IRA)

The IRA partially reversed this, enabling negotiations for specific drugs starting in 2026.
Key Details on the Law and Reversal:

• The 2003 Prohibition: The MMA stipulated that the Secretary of Health and Human Services (HHS) could not interfere with negotiations between drug manufacturers and private Medicare plans, effectively barring direct federal price negotiations.


• The Impact: This restriction, often called the “non-interference clause,” allowed pharmaceutical companies to set prices that Medicare plans were forced to accept.


• The Reversal (2022): The Inflation Reduction Act (IRA) allows HHS to negotiate prices for a limited number of high-cost, single-source drugs, beginning with 10 Part D drugs in 2026, and more in subsequent years.


• Ongoing Legal Challenges: The pharmaceutical industry has filed lawsuits to challenge the Medicare Drug Price Negotiation Program created by the IRA.

Past and Present: Natural Ice

In the 19th century, ice vendors used to ship blocks of ice from frozen rivers to more southerly cities. When refrigeration was invented, ice barons disparaged the ice they made as “artificial ice,” fake, not the real thing. But it didn’t work: Artificial ice was seen as cleaner, less impure, safer. When it also became cheaper to produce, it replaced the “natural” stuff rapidly. “To our 19th-century ancestors,” writes Postrel, “‘nature’ was a source of peril rather than purity.”